BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Other companies in BioVie’s space includes: Kezar Life Sciences (NASDAQ:KZR), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB) and Immuneering (NASDAQ:IMRX).
BioVie has a consensus price target of $10.80.
The stock price for BioVie (NASDAQ: BIVI) is $3.38 last updated November 20, 2024 at 7:54 PM EST.
There are no upcoming dividends for BioVie.
BioVie’s Q2 earnings are confirmed for Tuesday, February 11, 2025.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.